Treatment of Hepatocellular Carcinoma with Portal Vein Thrombosis by Sorafenib Combined with Hepatic Arterial Infusion Chemotherapy

Treatment with sorafenib prolongs both the median survival and time to progression by nearly 3 months in patients with advanced hepatocellular carcinoma. Although the effects of combining sorafenib therapy with other anticancer treatment modalities have not been clarified, combination treatment is s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Yang, Mi Yean, Jeong, Soung Won, Kim, Dong Kyun, Kim, Sang Gyune, Jang, Jae Young, Kim, Young Seok, Lee, Joon Seong, Kim, Boo Sung, Kim, Jung Hoon, Kim, Yong Jae
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2010
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2956362/
https://ncbi.nlm.nih.gov/pubmed/20981227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2010.4.3.423
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi